Leapmotor Debuts Global Product C10 and New Technologies at Munich, Launches Global Strategy
5.9.2023 20:27:00 EEST | Business Wire | Press release
On September 4th, Leapmotor made its debut at the IAA MOBILITY 2023 (hereinafter referred to as "Munich Motor Show"), where the "LEAP TOGETHER: Shaping a Shared Technological Future" global press conference was held. The event comprehensively showcased the latest achievement of all-domain in-house development, Leap 3.0 architecture, and the inaugural global model, the C10.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905065907/en/
C10 Model (Photo: Business Wire)
Leapmotor's Founder, Chairman, and CEO, Zhu Jiangming, emphasizes, “Leapmotor's globalization strategy encompasses the internationalization of both products and technology. Over 8 years of all-domain in-house development, Leapmotor has evolved from LEAP1.0 to LEAP3.0. With the arrival of our first global product based on LEAP3.0 architecture, the C10, all of Leapmotor's subsequent products will be designed and developed with a global mindset and adhere to global standards. In the next 2 years, Leapmotor will introduce 5 globally-oriented products in Europe, Asia-Pacific, the Middle East, the Americas, and other regions, offering intelligent mobility experiences to automotive consumers worldwide.”
As a technology-driven intelligent electric vehicle enterprise, Leapmotor remains steadfast in its commitment to all-domain in-house development of core technologies. With an unwavering commitment to shaping a shared future of intelligent mobility, Leapmotor remains devoted to delivering the finest smart mobility experience to all consumers.
Eight Years of All-domain In-house Development, LEAP 3.0 Embodies Cutting-Edge Intelligent Electric Technologies
Leap 3.0, with a central integrated electronic and electrical architecture as its core, encompasses several leading technologies, including CTC 2.0 (Cell-to-Chasis) technology, a latest oil-cooling electric drive, the intelligent cockpit with a Qualcomm Snapdragon 8295 chip, and a leading intelligent driving system. It is also built to global standards, and boasts an 88% interchangeability, imbuing each product with inherent intelligence, comfort, and safety traits.
Leapmotor's [Four-Leaf Clover] central integrated E/E architecture employs a central supercomputing platform, which seamlessly integrates the cockpit domain, pilot domain, power domain, and vehicle body domain, realizing the industry's pioneering convergence of these four domains. Furthermore, it enables vehicle-level seamless over-the-air (OTA) updates for five years. With over 500 reserved interfaces, it ensures Leapmotor to deliver an evolving and personalized driving experience.
Following last year's release of the package-less CTC technology, Leapmotor takes it a step further with CTC 2.0. This advanced technology eliminates modules, incorporates new safety features, and integrates a Battery Management System (BMS). This highly integrated battery-chassis equips the vehicle with attributes of extended range, enhanced safety, superior performance, and accelerated energy replenishment.
The latest oil-cooling electric drive features innovations that span from mid-voltage flat wire technology to high-voltage silicon carbide technology, offering power outputs ranging from 170kW to 250kW to accommodate both rear-wheel drive and all-wheel drive applications. The incorporation of high-voltage silicon carbide technology into the flat wire oil-cooling electric drive achieves a comprehensive efficiency of 92%, all while weighing only 76kg. This results in an ultra-compact and exceptionally powerful solution.
The Leapmotor intelligent cockpit system maximizes the capabilities of a Qualcomm Snapdragon 8295 chip, bestowing the cockpit with robust computing power and a seamless customer experience. The newly developed Leap OS intelligent desktop operating system caters to a multitude of driving scenarios, allowing customizable settings to accommodate diverse usage patterns.
At the intelligent driving level, the vehicle with Leap 3.0 is equipped with 30 high-performance perception hardware components, including LiDAR and an 8 million-pixel HD camera, delivering enhanced precision in perception. It is powered by an NVIDIA DRIVE Orin system-on-a-chip (SoC), which delivers 254 TOPS of computing to enable safe, high-speed and urban NAP intelligent-driving capabilities.
As an all-encompassing solution for intelligent electric vehicle technology, LEAP 3.0 stands as a prominent global leader in the field of intelligent electric vehicle technologies.
Leapmotor Initiates Globalization Strategy through Product Innovation and Technological Advancements
Leapmotor unveils C10 as the first model under LEAP3.0 architecture, marking its inaugural global strategic model. Embracing the signature design language of the Leapmotor family and leveraging the latest innovations of LEAP3.0, C10 embarks on an intelligent evolution to shape the future of mobility.
During the press conference, Mr. Zhu Jiangming stated, "Openness, co-creation, and global collaboration are key to achieving rapid proliferation of intelligent electric vehicles. Looking ahead, Leapmotor is not only an automobile manufacturer but also a comprehensive provider of intelligent electric vehicle solutions."
Globally, Leapmotor offers four different technology cooperation models, ranging from scratch to completion. Additionally, Leapmotor actively engages in strategic partnerships with world-renowned mobility ecosystem partners such as NVIDIA, ZF, Qualcomm, Bosch, and NXP.
The initiation of the global strategy is a critical step for Leapmotor as it leads the way with its competence of all-domain in-house development, driving the company's upward trajectory. It is also a demonstration of the synergy between brand strength, technological prowess, and influence.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905065907/en/
Contact information
Tammy Hu
hu_huiling@leapmotor.com
Lexi Liu
liu_xinyun@leapmotor.com
+86 15601869865
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 11:00:00 EET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 11:00:00 EET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 11:00:00 EET | Press release
The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying the foundations for the evolution of AI-supported oncological diagnostics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210610418/en/ On this
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 11:00:00 EET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 10:15:00 EET | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living with NT1. NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of physical, cognitive and psychosocial effects that can have a debilitating impact on many aspects of a person’s life, including work, education and social interactio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom